Inappropriate citations used to describe the pharmacology of botulinum toxin type A preparations in clinical use

By Zakine Benjamin   Pickett Andy M.   Maisonobe Pascal  

Journal of Rehabilitation Medicine, Vol. 41, Iss. 7, 2009-06 ,pp. : 591-592

Medical Journals Limited

Access to resources Recommend Favorite

Pharmacology of therapeutic botulinum toxin preparations

By Dressler Dirk   Benecke Reiner  

Disability and Rehabilitation, Vol. 29, Iss. 23, 2007-01 ,pp. : 1761-1768

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity

By Kaňovský Petr   Slawek Jaroslaw   Denes Zoltan   Platz Thomas   Comes Georg   Grafe Susanne   Pulte Irena  

Journal of Rehabilitation Medicine, Vol. 43, Iss. 6, 2011-05 ,pp. : 486-492

Medical Journals Limited

Access to resources Recommend Favorite

Comparative trial of a novel botulinum neurotoxin type A versus onabotulinumtoxinA in the treatment of glabellar lines: A multicenter, randomized, double‐blind, active‐controlled study

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 2, 2015-02 ,pp. : 227-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Botulinum neurotoxin treatment for spasticity: The role of electromyography guidance

By Vilholm Ole Jakob   Nielsen Jens Bo  

Journal of Rehabilitation Medicine, Vol. 46, Iss. 7, 2014-07 ,pp. : 715-716

Medical Journals Limited

Access to resources Recommend Favorite